EFFECT OF DORNASE ALFA ON INFLAMMATION AND LUNG FUNCTION: POTENTIAL ROLE IN THE EARLY TREATMENT OF CYSTIC FIBROSIS

ανά Konstan, Michael W., Ratjen, Felix
Έκδοση 2011

Inhaled Hypertonic Saline in Infants and Young Children with Cystic Fibrosis

ανά Dasenbrook, Elliott C., Konstan, Michael W.
Τόπος έκδοσης JAMA (2012)

Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease

ανά VanDevanter, Donald R, Konstan, Michael W
Τόπος έκδοσης Clin Investig (Lond) (2012)

Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease

ανά Sagel, Scott D., Chmiel, James F., Konstan, Michael W.
Έκδοση 2007

The Role of Inhaled Corticosteroids in the Management of Cystic Fibrosis

ανά Ross, Kristie R., Chmiel, James F., Konstan, Michael W.
Έκδοση 2009

Antibiotic and Anti-Inflammatory Therapies for Cystic Fibrosis

ανά Chmiel, James F., Konstan, Michael W., Elborn, J. Stuart
Έκδοση 2013

Characterizing aggressiveness and predicting future progression of CF lung disease

ανά Konstan, Michael W., Wagener, Jeffrey S., VanDevanter, Donald R.
Έκδοση 2009

Improvements in Lung Function and Height among Cohorts of 6-Year-Olds with Cystic Fibrosis from 1994 to 2012

ανά VanDevanter, Donald R., Pasta, David J., Konstan, Michael W.
Τόπος έκδοσης J Pediatr (2014)

ASSOCIATION BETWEEN THE INTRODUCTION OF A NEW CYSTIC FIBROSIS INHALED ANTIBIOTIC CLASS AND CHANGE IN PREVALENCE OF PATIENTS RECEIVING MULTIPLE INHALED ANTIBIOTIC CLASSES

ανά Dasenbrook, Elliott C., Konstan, Michael W., VanDevanter, Donald R.
Τόπος έκδοσης J Cyst Fibros (2014)

TREATMENT AND DEMOGRAPHIC FACTORS AFFECTING TIME TO NEXT PULMONARY EXACERBATION IN CYSTIC FIBROSIS

ανά VanDevanter, Donald R., Pasta, David J., Konstan, Michael W.
Τόπος έκδοσης J Cyst Fibros (2015)

IV-Treated Pulmonary Exacerbations in the Prior Year: An Important Independent Risk Factor for Future Pulmonary Exacerbation in Cystic Fibrosis

ανά VanDevanter, Donald R., Morris, Nathan J., Konstan, Michael W.
Τόπος έκδοσης J Cyst Fibros (2015)

Clinical Use of Ibuprofen Is Associated with Slower FEV(1) Decline in Children with Cystic Fibrosis

ανά Konstan, Michael W., Schluchter, Mark D., Xue, Wei, Davis, Pamela B.
Έκδοση 2007

Pseudomonas aeruginosa antimicrobial susceptibility test (AST) results and pulmonary exacerbation treatment responses in cystic fibrosis

ανά VanDevanter, Donald R., Heltshe, Sonya L., Hilliard, Jay B., Konstan, Michael W.
Τόπος έκδοσης J Cyst Fibros (2020)

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations

ανά VanDevanter, Donald R, O'Riordan, Mary A, Blumer, Jeffrey L, Konstan, Michael W
Έκδοση 2010

Coefficients of Fat and Nitrogen Absorption in Healthy Subjects and Individuals with Cystic Fibrosis

ανά Borowitz, Drucy, Konstan, Michael W., O'Rourke, Anna, Cohen, Morty, Hendeles, Leslie, Murray, Frederick T.
Έκδοση 2007

Clinical Use of Tobramycin Inhalation Solution (TOBI(®)) Shows Sustained Improvement in FEV1 in Cystic Fibrosis

ανά Konstan, Michael W., Wagener, Jeffrey S., Pasta, David J., Millar, Stefanie J., Morgan, Wayne J.
Έκδοση 2013

Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: the EVOLVE trial

ανά Konstan, Michael W, Geller, David E, Minić, Predrag, Brockhaus, Florian, Zhang, Jie, Angyalosi, Gerhild
Έκδοση 2010

Classifying Severity of Cystic Fibrosis Lung Disease Using Longitudinal Pulmonary Function Data

ανά Schluchter, Mark D., Konstan, Michael W., Drumm, Mitchell L., Yankaskas, James R., Knowles, Michael R.
Έκδοση 2006

Association of Socioeconomic Status with the Use of Chronic Therapies and Healthcare Utilization in Children with Cystic Fibrosis

ανά Schechter, Michael S., McColley, Susanna A., Silva, Stefanie, Haselkorn, Tmirah, Konstan, Michael W., Wagener, Jeffrey S.
Έκδοση 2009

Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis

ανά Konstan, Michael W, Accurso, Frank J, Nasr, Samya Z, Ahrens, Richard C, Graff, Gavin R
Έκδοση 2013